Greenwich Rx voluntarily recalls compounded glutathione injections over possible elevated endotoxin levels

Greenwich Rx, a 503A compounding pharmacy based in Tomball, Texas, announced a voluntary nationwide recall of specific lots of its compounded glutathione injection product. The recall is being issued to consumers.

The recall was triggered by concerns that the product may contain elevated endotoxin levels, which can cause serious medical reactions such as fever, low blood pressure, inflammatory responses, anaphylactic shock, or even death.

The affected product is a 200 mg/mL glutathione injection supplied in 10 mL multidose vials intended for subcutaneous use. Greenwich Rx listed several lot numbers with beyond‑use dates ranging from February to July 2026. The company reported two emergency‑department cases where patients received the glutathione product intravenously, a route for which it was not formulated.